- JP-listed companies
- KISSEI PHARMACEUTICAL CO.,LTD.
- Balance sheet
KISSEI PHARMACEUTICAL CO.,LTD.【JP:4547】Balance sheet
Market cap
¥229B
P/E ratio
15.6x
| 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Cash and cash equivalents | - | 27,241 | 25,666 | 27,109 | 24,371 | 26,325 | 36,329 | 20,456 | 30,013 | 25,893 | 22,894 | 25,169 |
| Marketable securities, current | - | 25,132 | 24,476 | 21,039 | 23,288 | 23,039 | 23,342 | 23,998 | 23,139 | 23,706 | 23,039 | 23,485 |
| Accounts receivable, net | - | 23,675 | 24,966 | 24,730 | 28,873 | 26,963 | 19,462 | 23,058 | - | - | - | - |
| Inventories | - | 6,027 | 5,980 | 5,504 | 4,933 | 5,847 | 6,926 | 11,066 | 10,491 | 12,679 | 14,310 | 13,706 |
| Total current assets | - | 97,361 | 100,051 | 97,218 | 100,599 | 95,782 | 96,677 | 92,965 | 99,342 | 100,641 | 104,551 | 106,980 |
| Property, plant and equipment, net | - | 26,852 | 26,758 | 26,308 | 26,396 | 25,503 | 24,605 | 24,290 | 24,074 | 24,579 | 24,861 | 27,069 |
| Marketable securities, non-current | - | 54,382 | 62,300 | 58,344 | 81,194 | 86,958 | 105,158 | 138,133 | 96,631 | 74,769 | 106,361 | 84,869 |
| Total non-current assets | - | 84,122 | 93,294 | 89,582 | 112,487 | 117,739 | 135,117 | 175,895 | 138,745 | 120,558 | 156,377 | 137,079 |
| Total assets | - | 181,484 | 193,345 | 186,801 | 213,087 | 213,522 | 231,794 | 268,861 | 238,087 | 221,200 | 260,929 | 244,059 |
| Accounts payable | - | 6,045 | 5,829 | 4,849 | 4,894 | 4,347 | 5,237 | 7,909 | 4,104 | 4,617 | 4,893 | 4,602 |
| Short-term debt | - | 1,815 | 1,815 | 1,800 | 1,757 | 1,764 | 1,746 | 1,743 | 1,640 | 1,490 | 1,340 | 1,280 |
| Total current liabilities | - | 18,934 | 19,608 | 15,656 | 17,448 | 13,801 | 17,024 | 18,245 | 18,744 | 14,957 | 17,663 | 16,578 |
| Long-term debt, non-current | - | 1,463 | 1,488 | 1,656 | 1,876 | 1,930 | 13 | - | - | - | - | - |
| Total non-current liabilities | - | 11,829 | 15,612 | 13,361 | 19,546 | 17,013 | 21,800 | 30,662 | 17,163 | 11,428 | 22,129 | 17,354 |
| Total liabilities | - | 30,764 | 35,220 | 29,017 | 36,994 | 30,814 | 38,824 | 48,907 | 35,907 | 26,385 | 39,793 | 33,933 |
| Common stock and paid-in capital | - | 48,610 | 48,603 | 48,582 | 48,582 | 48,582 | 48,582 | 48,582 | 48,582 | 48,582 | 48,582 | 48,582 |
| Retained earnings | - | 95,565 | 96,230 | 101,755 | 102,834 | 106,026 | 106,461 | 109,270 | 118,183 | 125,576 | 127,310 | 131,488 |
| Stockholders' equity | 142,821 | 150,720 | 158,125 | 157,783 | 176,092 | 182,707 | 192,970 | 219,953 | 202,180 | 194,814 | 221,136 | 210,126 |